|
TBC1D22B expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.10079945159214E-10 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.78839999873415E-08 |
| Normal-vs-Stage2 |
3.723500E-02 |
| Normal-vs-Stage3 |
4.126300E-02 |
| Normal-vs-Stage4 |
1.085190E-01 |
| Stage1-vs-Stage2 |
1.872200E-01 |
| Stage1-vs-Stage3 |
2.664000E-01 |
| Stage1-vs-Stage4 |
7.272000E-01 |
| Stage2-vs-Stage3 |
7.686600E-01 |
| Stage2-vs-Stage4 |
1.726360E-01 |
| Stage3-vs-Stage4 |
2.447600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.74189998378449E-09 |
| Normal-vs-AfricanAmerican |
1.25230000003196E-06 |
| Normal-vs-Asian |
2.579200E-01 |
| Caucasian-vs-AfricanAmerican |
4.251000E-01 |
| Caucasian-vs-Asian |
5.756800E-01 |
| AfricanAmerican-vs-Asian |
5.111000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.82410000437727E-08 |
| Normal-vs-Female |
9.93730000509174E-08 |
| Male-vs-Female |
8.821600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
3.611600E-04 |
| Normal-vs-Extreme_Weight |
4.759600E-04 |
| Normal-vs-Obese |
1.409320E-04 |
| Normal-vs-Extreme_Obese |
3.375500E-03 |
| Normal_Weight-vs-Extreme_Weight |
3.141400E-01 |
| Normal_Weight-vs-Obese |
7.138100E-02 |
| Normal_Weight-vs-Extreme_Obese |
6.259700E-02 |
| Extreme_Weight-vs-Obese |
3.992800E-01 |
| Extreme_Weight-vs-Extreme_Obese |
3.855600E-01 |
| Obese-vs-Extreme_Obese |
9.204600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
6.445500E-04 |
| Normal-vs-Age(41-60Yrs) |
3.61549679084305E-11 |
| Normal-vs-Age(61-80Yrs) |
2.39069999999897E-05 |
| Normal-vs-Age(81-100Yrs) |
1.226400E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.633900E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.557200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.416100E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.551200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.547800E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.262000E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.82265313952712E-12 |
| Normal-VS-Type2 PRCC |
9.139000E-03 |
| Normal-VS-KIRP CIMP |
8.112000E-02 |
| Normal-VS-Unclassified PRCC |
3.422400E-04 |
| Type1 PRCC-VS-Type2 PRCC |
7.582400E-01 |
| Type1 PRCC-VS-KIRP CIMP |
9.543400E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
8.147000E-01 |
| Type2 PRCC-VS-KIRP CIMP |
8.827400E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
6.940800E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
8.631200E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.082160E-02 |
| Normal-vs-N1 |
7.757100E-04 |
| Normal-vs-N2 |
7.002400E-01 |
| N0-vs-N1 |
9.004200E-01 |
| N0-vs-N2 |
5.828200E-01 |
| N1-vs-N2 |
2.927200E-01 |
|
|
